Identification and evaluation of potent Middle East...

Main
Identification and evaluation of potent...

Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors

Vathan Kumar, Jin Soo Shin, Jiun-Jie Shie

0 / 0

Bu kitabı nə dərəcədə bəyəndiniz?

Yüklənmiş faylın keyfiyyəti necədir?

Kitabın keyfiyyətini qiymətləndirə bilmək üçün onu yükləyin

Yüklənmiş faylların keyfiyyəti necədir?

Antiviral Research, 141 (2017) 101-106. doi:10.1016/j.antiviral.2017.02.007

İl:

2017

Nəşriyyat:

Elsevier

Dil:

english

Səhifələr:

6

Fayl:

PDF, 914 KB

IPFS:

,

english, 2017

Onlayn oxumaq

formatına konvertasiya yerinə yetirilir

formatına konvertasiya baş tutmadı

Bəlkə Sizə maraqlıdır

Jo Seri & Kim Suwon & Kim Dae Yong & Kim Mi-Sun & Shin Dong Hae — Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

Alexzander A. A. Asea;Punit Kaur; — Coronavirus Therapeutics Volume I

Lisa E. Gralinski, Vineet D. Menachery — Return of the Coronavirus: 2019-nCoV

Yuefei Jin, Haiyan Yang, Wangquan Ji — Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Mahmoud Kandeel, Mohammed Al-Nazawi — Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

Li-sheng Wang, Yi-ru Wang, Da-wei Ye, Qing-quan Li — A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence

Le Chang, Ying Yan, Lunan Wang — Coronavirus Disease 2019: Coronaviruses and Blood Safety

Balachandar Vellingiri, Kaavya Jayaramayya, Mahalaxmi Iyer, Arul Narayanasamy, Vivekanandhan Govindasamy — COVID-19: A promising cure for the global panic

David S. Hui — Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)

Shio-Shin Jean, Ping-Ing Lee, Po-Ren Hsueh — Treatment options for COVID-19: The reality and challenges

Xiaowei Li, Manman Geng, Yizhao Peng — Molecular immune pathogenesis and diagnosis of COVID-19

Shibo Jiang, Christopher Hillyer, Lanying Du — Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo — Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2

E. De Clercq (Eds.) — Advances in Antiviral Drug Design 5

John E. Macor (Eds.) — Annual Reports in Medicinal Chemistry 46

Adnan I. Qureshi, Omar Saeed, Uzma Syed — Coronavirus Disease: From Origin to Outbreak

Mohammed S. Razzaque M.D., Ph.D. (auth.) — Fibrogenesis: Cellular and Molecular Basis

Lisa A. Beltz; — Pathogenic Coronaviruses of Humans and Animals

Wieslaw M. Kazmierski — Antiviral Drugs: From Basic Discovery Through Clinical Trials

Hanadi Talal Ahmedah, Muhammad Riaz, Sagheer Ahmed, Marius Alexandru Moga — The COVID-19 Pandemic: A Multidisciplinary Review of Diagnosis, Prevention, and Treatment

Debmalya Barh (editor), Kenneth Lundstrom (editor) — COVID-19: From Bench to Bedside

Jen-Tsung Chen — Bioactive Compounds Against SARS-CoV-2

Jen-Tsung Chen — Traditional and Herbal Medicines for COVID-19

Kamal, Niaz;Muhammad Farrukh, Nisar; — Coronavirus Disease-19 (COVID-19): Different Models and Treatment Strategies

Kunal Roy — In Silico Modeling of Drugs Against Coronaviruses: Computational Tools and Protocols

Sunil K Lal — Emerging viral diseases of Southeast Asia

Herbert E. Kaufman (auth.), Julian Adams, Vincent J. Merluzzi (eds.) — The Search for Antiviral Drugs: Case Histories from Concept to Clinic

E. De Clercq (Eds.) — Advances in Antiviral Drug Design

Yu-chen Cao, Qi-xin Deng, Shi-xue Dai — Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence

Hanadi Talal Ahmedah (editor), Muhammad Riaz (editor), Sagheer Ahmed (editor), Marius Alexandru Moga (editor) — The Covid-19 Pandemic: A Multidisciplinary Review of Diagnosis, Prevention, and Treatment

,,,, — Biotechnology to Combat COVID-19

Desai Manoj C. — Successful strategies for the discovery of antiviral drugs

David S. Hui, Giovanni A. Rossi, Sebastian L. Johnston — SARS, MERS And Other Viral Lung Infections

Alexzander A. A. Asea, Punit Kaur — Coronavirus Therapeutics – Volume I Basic Science and Therapy Development

Helga Rübsamen-Schaeff, Helmut Buschmann — New Drug Development for Known and Emerging Viruses

Açar ifadələr